Ramona Doyle
Chief Executive Officer bij The MAVEN Project
Actieve functies van Ramona Doyle
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The MAVEN Project | Chief Executive Officer | 01-09-2020 | - |
The University of California, San Francisco | Corporate Officer/Principal | 01-10-2011 | - |
Loopbaan van Ramona Doyle
Eerdere bekende functies van Ramona Doyle
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
RECURSION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-12-2020 | 07-06-2022 |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01-01-2017 | 01-05-2018 |
California Institute for Regenerative Medicine | Corporate Officer/Principal | 01-07-2015 | 01-07-2016 |
Stanford University School of Medicine | Corporate Officer/Principal | 01-01-1995 | 01-01-2008 |
Opleiding van Ramona Doyle
University of Oxford | Graduate Degree |
Sewanee-The University of the South | Undergraduate Degree |
Emory University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 9 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 2 |
Sectoraal
Consumer Services | 6 |
Health Technology | 2 |
Government | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
RECURSION PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
California Institute for Regenerative Medicine | Government |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Commercial Services |
The MAVEN Project |
- Beurs
- Insiders
- Ramona Doyle
- Ervaring